Skip to content

Efficacy of restarting anti-TNF agents after surgery in patients with Crohn disease

Efficacy of restarting anti-TNF agents after surgery in patients with Crohn disease - Efficacy of restarting anti-TNF agents after surgery in CD patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027683
Enrollment
40
Registered
2017-06-08
Start date
2016-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn disease

Interventions

None listed

Sponsors

Okayama University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: CD patients who underwent surgical resection for intestinal lesions and were administered anti-TNF agents after surgery

Exclusion criteria

Exclusion criteria: surgery without anastomosis, follow-up period less than 1 year after surgery

Design outcomes

Primary

MeasureTime frame
the efficacy of postoperative anti-TNF after surgery

Countries

Japan

Contacts

Public ContactSakiko Hiraoka

Okayama University Graduate School of Medicine Department of Gastroenterology and Hepatology

sakikoh@cc.okayama-.u.ac.jp086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026